Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 6 studies | 25% ± 11% | |
endothelial cell | 5 studies | 24% ± 9% | |
epithelial cell | 5 studies | 31% ± 18% | |
pericyte | 3 studies | 19% ± 5% | |
astrocyte | 3 studies | 22% ± 6% | |
dendritic cell | 3 studies | 25% ± 11% | |
abnormal cell | 3 studies | 20% ± 5% | |
basal cell | 3 studies | 28% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 20% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3526.40 | 1445 / 1445 | 100% | 42.04 | 183 / 183 |
ovary | 100% | 5459.26 | 180 / 180 | 100% | 49.37 | 429 / 430 |
prostate | 100% | 4812.69 | 245 / 245 | 100% | 26.39 | 500 / 502 |
brain | 100% | 2994.60 | 2632 / 2642 | 100% | 36.59 | 704 / 705 |
intestine | 100% | 3883.55 | 966 / 966 | 99% | 25.76 | 524 / 527 |
stomach | 100% | 2721.46 | 359 / 359 | 99% | 26.22 | 284 / 286 |
skin | 100% | 3390.09 | 1809 / 1809 | 99% | 24.63 | 468 / 472 |
thymus | 100% | 5418.11 | 653 / 653 | 99% | 25.20 | 599 / 605 |
lung | 100% | 3187.22 | 577 / 578 | 99% | 25.29 | 1143 / 1155 |
bladder | 100% | 4147.62 | 21 / 21 | 99% | 25.07 | 497 / 504 |
breast | 100% | 4247.95 | 459 / 459 | 98% | 23.57 | 1101 / 1118 |
uterus | 100% | 5051.25 | 170 / 170 | 98% | 27.95 | 452 / 459 |
pancreas | 100% | 2706.26 | 328 / 328 | 98% | 20.85 | 175 / 178 |
adrenal gland | 100% | 3080.29 | 258 / 258 | 95% | 20.59 | 219 / 230 |
kidney | 100% | 2859.67 | 89 / 89 | 93% | 13.64 | 842 / 901 |
liver | 100% | 1677.12 | 226 / 226 | 85% | 9.71 | 347 / 406 |
adipose | 100% | 3618.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 26.02 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.36 | 29 / 29 |
spleen | 100% | 3848.09 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.46 | 1 / 1 |
blood vessel | 100% | 3181.20 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2319.59 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3043.97 | 855 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.72 | 44 / 45 |
peripheral blood | 76% | 1624.39 | 704 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0045475 | Biological process | locomotor rhythm |
GO_2000736 | Biological process | regulation of stem cell differentiation |
GO_0006302 | Biological process | double-strand break repair |
GO_0007165 | Biological process | signal transduction |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042659 | Biological process | regulation of cell fate specification |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_1902499 | Biological process | positive regulation of protein autoubiquitination |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005874 | Cellular component | microtubule |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016581 | Cellular component | NuRD complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | MTA1 |
Protein name | Metastasis-associated protein MTA1 Metastasis associated 1 |
Synonyms | |
Description | FUNCTION: Transcriptional coregulator which can act as both a transcriptional corepressor and coactivator . Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin . In the NuRD complex, regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target DNA . In conjunction with other components of NuRD, acts as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A . Acts as a transcriptional coactivator of BCAS3, and SUMO2, independent of the NuRD complex . Stimulates the expression of WNT1 by inhibiting the expression of its transcriptional corepressor SIX3 (By similarity). Regulates p53-dependent and -independent DNA repair processes following genotoxic stress . Regulates the stability and function of p53/TP53 by inhibiting its ubiquitination by COP1 and MDM2 thereby regulating the p53-dependent DNA repair . Plays a role in the regulation of the circadian clock and is essential for the generation and maintenance of circadian rhythms under constant light and for normal entrainment of behavior to light-dark (LD) cycles (By similarity). Positively regulates the CLOCK-BMAL1 heterodimer mediated transcriptional activation of its own transcription and the transcription of CRY1 (By similarity). Regulates deacetylation of BMAL1 by regulating SIRT1 expression, resulting in derepressing CRY1-mediated transcription repression (By similarity). With TFCP2L1, promotes establishment and maintenance of pluripotency in embryonic stem cells (ESCs) and inhibits endoderm differentiation (By similarity). .; FUNCTION: [Isoform Short]: Binds to ESR1 and sequesters it in the cytoplasm and enhances its non-genomic responses. . |
Accessions | ENST00000331320.12 [Q13330-1] ENST00000406191.5 ENST00000438610.5 [Q13330-2] ENST00000434050.5 ENST00000424723.5 ENST00000405646.5 [Q13330-3] Q13330 F8W9Y9 ENST00000435036.6 ENST00000551236.5 H7C3F3 E7ESY4 H0YIT0 H0Y4T7 |